Form D · Other
BioFluff Inc.
San Francisco, CA · CIK 0001954662
Offering snapshot reported Oct 23, 2023 · SEC filing
- Reported sold
- $2.5M Offering amount: $2.5M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 20, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 23, 2023 | Initial | $2,500,000 | No comparison | 6 | SEC filing |
| Jun 26, 2023 | Amendment | $506,500 | -$63,500vs Jan 17, 2023 | 6 | SEC filing |
| Jan 17, 2023 | Amendment | $570,000 | $50,000vs Dec 29, 2022 | 7 | SEC filing |
| Dec 29, 2022 | Amendment | $520,000 | $170,000vs Nov 18, 2022 | 6 | SEC filing |
| Nov 18, 2022 | Initial | $350,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-495407
Source: Form D, filed Oct 23, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Martin Stuebler | Executive |
Issuer details
Industry: Other (See others in industry)
Address:
21 Buena Vista Avenue East
San Francisco, CA, 94117
San Francisco, CA, 94117